Collectively, these markers CD73+ and CD90+/CD105+ promote tumor growth, angiogenesis, and metastasis in breast cancer cells, and positive expression of these markers in PDOs was an indicator of the MSC phenotype of the original tumor. This evidence concerns the gene NT5E and breast cancer.